HIV positive pregnant women receiving antiretrovirals, using in Congo
Congo: HIV positive pregnant women receiving antiretrovirals, using was 7.0% in 2011. ◆ Volatile
HIV positive pregnant women receiving antiretrovirals, using in Congo, 2004–2011
Source: http://data.unaids.org/pub/GlobalReport/2008/. Measured in %; high estimate.
Analysis
Congo recorded 7.0% for hiv positive pregnant women receiving antiretrovirals, using in 2011. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 69.6% on the previous year and down 12.5% over ten years.
That places Congo 36th out of 38 countries with data for 2011, putting it in the bottom quarter.
HIV positive pregnant women receiving antiretrovirals, using in Congo, year by year
| Year | %; high estimate | Change |
|---|---|---|
| 2004 | 8.0% | — |
| 2005 | 28.0% | +250.0% |
| 2006 | 9.0% | -67.9% |
| 2007 | 7.0% | -22.2% |
| 2009 | 23.0% | +228.6% |
| 2011 | 7.0% | -69.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 15.0% | 7.0% | 28.0% | 5 |
| 2010s | 7.0% | 7.0% | 7.0% | 1 |
Countries ranked near Congo
- 33 Madagascar 16.0% compare
- 34 Chad 14.0% compare
- 35 Congo, Democratic Republic of the 11.0% compare
- 37 Mauritania 4.0% compare
- 38 Eritrea 0.0% compare
More health data for Congo
- Un projection of annual infant deaths, annual growth rate -0.4813 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9705 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 759.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,688 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.065 units per person (2025)
- Population ages 05-09, male, annual growth rate 0.6314 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0662 units per person (2025)
- Population ages 10-14, female, annual growth rate 1.23 % change on previous year (2025)
Frequently asked questions
- What is hiv positive pregnant women receiving antiretrovirals, using in Congo?
- Hiv positive pregnant women receiving antiretrovirals, using in Congo was 7.0% in 2011, according to http://data.unaids.org/pub/GlobalReport/2008/.
- What is the highest hiv positive pregnant women receiving antiretrovirals, using recorded in Congo?
- The highest recorded value was 28.0% in 2005.
- What is the lowest hiv positive pregnant women receiving antiretrovirals, using recorded in Congo?
- The lowest recorded value was 7.0% in 2007.
- How does Congo rank for hiv positive pregnant women receiving antiretrovirals, using?
- Congo ranks 36th out of 38 countries with data for 2011.
- Is hiv positive pregnant women receiving antiretrovirals, using rising or falling in Congo?
- Over the last ten years it is down 12.5%. The long-run trend across the full record is volatile.
- Where does this Congo data come from?
- The figures come from http://data.unaids.org/pub/GlobalReport/2008/, published as part of HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.